UNI-EN 183:New capital of "Sopharma" AD entered in the Commercial Register
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 183 | / | 2023 | |||||||
| Date of issue: | 2023-10-06 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| New capital of "Sopharma" AD entered in the Commercial Register | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| “Sopharma” AD (the Company) notifies that as a result of the conditional capital increase through the exercise of warrants from an issue with ISIN BG9200001212 the new capital of "Sopharma" AD amounting to BGN 172,590,578 was entered in the Commercial Register, under number 20231006154857. A procedure for registration of the new issue in the registers of the Financial Supervision Commission and "Central Depository" AD and the admission of the shares from the increase to trading on "Bulgarian Stock Exchange" AD is pending. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| SFA_2023_Capital_increase_EN_espi.pdf SFA_2023_Capital_increase_EN_espi.pdf | New capital of "Sopharma" AD entered in the Commercial Register | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2023-10-06 | Ognian Donev | Executive Director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 16.2 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
